US68622P1093
US68622P1093
Oric Pharmaceuticals, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 1.24B EUR | 1.12B EUR | 1.31B EUR |
Enterprise Value | 988.18M EUR | 1.09B EUR | 1.26B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | -7.17x | -- | -- |
Price to Sales | -- | -- | -- |
Price to Book | 3.26x | 2.94x | 3.16x |
EV/Revenue | -- | -- | -- |
EV/EBITDA | -6.38x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -5.54% | -10% | -8.48% |